It has been proved that in breast cancer and prostate cancer, FBL can promote cancer cell proliferation by regulating mRNA translation and controlling rRNA methylation (El Hassouni et al., 2019; Zhang et al., 2021). The gene discussed is FBL; the disease is cancer.